Galectin Therapeutics Inc. (GALT)
NASDAQ·Healthcare·Biotechnology
$3.41
+6.90%
Mkt Cap $195.59M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+222.6%
Consensus $11.00 vs current $3.41
NASDAQ·Healthcare·Biotechnology
$3.41
+6.90%
Mkt Cap $195.59M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+222.6%
Consensus $11.00 vs current $3.41